Literature DB >> 10636149

A conventional and magnetization transfer MRI study of the cervical cord in patients with MS.

M Filippi1, M Bozzali, M A Horsfield, M A Rocca, M P Sormani, G Iannucci, B Colombo, G Comi.   

Abstract

OBJECTIVE: To evaluate the contribution made by cervical cord damage, assessed using a fast short-tau inversion recovery (fast-STIR) sequence and magnetization transfer ratio (MTR) histogram analysis to the clinical manifestations of MS.
BACKGROUND: Previous studies have failed to show significant correlations between the number and extent of T2 spinal cord lesions and the clinical status of patients with MS. Fast-STIR is more sensitive than T2-weighted imaging for detecting cervical cord MS lesions. MTR histogram analysis provides estimates of the overall disease burden in the cervical cord with higher pathologic specificity to the more destructive aspects of MS than T2-weighted scans.
METHODS: We obtained fast-STIR and magnetization transfer (MT) scans from 96 patients with MS (52 with relapsing-remitting [RRMS], 33 with secondary progressive [SPMS], and 11 with primary progressive [PPMS] MS) and 21 control subjects. Dual-echo scans of the brain were also obtained and lesion load measured.
RESULTS: Eighty-one of the patients with MS had an abnormal cervical cord scan. Patients with SPMS had more cervical cord lesions and more images with visible cervical cord damage than did patients with RRMS or PPMS (p = 0.04). The entire cohort of patients with MS had lower average MTR of the cervical cord (p = 0.006) than control subjects. Compared to control subjects, patients with RRMS had similar cervical cord MTR histogram-derived measures, whereas those with PPMS had lower average MTR (p = 0.01) and peak height (p = 0.02). Patients with SPMS had lower histogram peak height than did those with RRMS (p = 0.03). The peak position and height of the cervical cord MTR histogram were independent predictors of the probability of having locomotor disability. We found no correlation between brain T2 lesion load and any of the cervical cord MTR histogram metrics.
CONCLUSIONS: This study shows that the amount and severity of MS pathology in the cervical cord are greater in the progressive forms of the disease. An accurate assessment of cervical cord damage in MS gives information that can be used in part to explain the clinical manifestations of the disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10636149     DOI: 10.1212/wnl.54.1.207

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  26 in total

1.  Magnetic resonance imaging, magnetisation transfer imaging, and diffusion weighted imaging correlates of optic nerve, brain, and cervical cord damage in Leber's hereditary optic neuropathy.

Authors:  M Inglese; M Rovaris; S Bianchi; L La Mantia; G L Mancardi; A Ghezzi; P Montagna; F Salvi; M Filippi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-04       Impact factor: 10.154

Review 2.  Clinical trials and clinical practice in multiple sclerosis: conventional and emerging magnetic resonance imaging technologies.

Authors:  Massimo Filippi; Maria A Rocca; Marco Rovaris
Journal:  Curr Neurol Neurosci Rep       Date:  2002-05       Impact factor: 5.081

3.  Mean diffusivity and fractional anisotropy histograms of patients with multiple sclerosis.

Authors:  M Cercignani; M Inglese; E Pagani; G Comi; M Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2001-05       Impact factor: 3.825

4.  Benefit of repetitive intrathecal triamcinolone acetonide therapy in predominantly spinal multiple sclerosis: prediction by upper spinal cord atrophy.

Authors:  Carsten Lukas; Barbara Bellenberg; Horst K Hahn; Jan Rexilius; Robert Drescher; Kerstin Hellwig; Odo Köster; Sebastian Schimrigk
Journal:  Ther Adv Neurol Disord       Date:  2009-11       Impact factor: 6.570

Review 5.  Pharmacological treatment of early multiple sclerosis.

Authors:  Olaf Stüve; Jeffrey L Bennett; Bernhard Hemmer; Heinz Wiendl; Michael K Racke; Amit Bar-Or; Wei Hu; Robert Zivadinov; Martin S Weber; Scott S Zamvil; Maria F Pacheco; Til Menge; Hans-Peter Hartung; Bernd C Kieseier; Elliot M Frohman
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 6.  MRI in multiple sclerosis: what's inside the toolbox?

Authors:  Mohit Neema; James Stankiewicz; Ashish Arora; Zachary D Guss; Rohit Bakshi
Journal:  Neurotherapeutics       Date:  2007-10       Impact factor: 7.620

Review 7.  Spinal cord MRI in multiple sclerosis--diagnostic, prognostic and clinical value.

Authors:  Hugh Kearney; David H Miller; Olga Ciccarelli
Journal:  Nat Rev Neurol       Date:  2015-05-26       Impact factor: 42.937

8.  Magnetization transfer and diffusion tensor MR imaging of acute disseminated encephalomyelitis.

Authors:  Matilde Inglese; Fabrizio Salvi; Giuseppe Iannucci; Gian Luigi Mancardi; Mario Mascalchi; Massimo Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2002-02       Impact factor: 3.825

9.  Spatial distribution of multiple sclerosis lesions in the cervical spinal cord.

Authors:  Dominique Eden; Charley Gros; Atef Badji; Sara M Dupont; Benjamin De Leener; Josefina Maranzano; Ren Zhuoquiong; Yaou Liu; Tobias Granberg; Russell Ouellette; Leszek Stawiarz; Jan Hillert; Jason Talbott; Elise Bannier; Anne Kerbrat; Gilles Edan; Pierre Labauge; Virginie Callot; Jean Pelletier; Bertrand Audoin; Henitsoa Rasoanandrianina; Jean-Christophe Brisset; Paola Valsasina; Maria A Rocca; Massimo Filippi; Rohit Bakshi; Shahamat Tauhid; Ferran Prados; Marios Yiannakas; Hugh Kearney; Olga Ciccarelli; Seth A Smith; Constantina Andrada Treaba; Caterina Mainero; Jennifer Lefeuvre; Daniel S Reich; Govind Nair; Timothy M Shepherd; Erik Charlson; Yasuhiko Tachibana; Masaaki Hori; Kouhei Kamiya; Lydia Chougar; Sridar Narayanan; Julien Cohen-Adad
Journal:  Brain       Date:  2019-03-01       Impact factor: 13.501

10.  Spinal cord lesions and clinical status in multiple sclerosis: A 1.5 T and 3 T MRI study.

Authors:  J M Stankiewicz; M Neema; D C Alsop; B C Healy; A Arora; G J Buckle; T Chitnis; C R G Guttmann; D Hackney; R Bakshi
Journal:  J Neurol Sci       Date:  2009-04-15       Impact factor: 3.181

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.